Jeffrey M. Arbeit and David T. Curiel, Washington University School of Medicine (IMAGE)

WashU Medicine

Jeffrey M. Arbeit and David T. Curiel, Washington University School of Medicine

Caption

Embargoed until 5 p.m. ET Monday, Dec. 23, 2013. Working in mice, researchers at Washington University School of Medicine in St. Louis report developing a gene delivery method long sought in the field of gene therapy: a deactivated virus carrying a gene of interest that can be injected into the bloodstream and make its way to the right cells. Jeffrey M. Arbeit, MD, (left) and David T. Curiel, MD, PhD, and their colleagues designed a viral vector that homes in on the abnormal blood vessels of tumors, opening up new therapeutic possibilities for gene therapy against cancer and other conditions that involve abnormal vasculature.

Credit

Robert J. Boston

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.